Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Colombi

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
Human Mutation|July 17, 1999
Three homozygous PTC mutations in the collagen type VII gene of patients affected by recessive dystrophic epidermolysis bullosa: analysis of transcript levels in dermal fibroblastsR Gardella, N Zoppi, S Ferraboli, et al.
British Journal of Cancer|November 1, 1983
Non interference by heparin with the cytostatic effect of adriamycin: an in vitro study on a human promyelocytic leukaemia cell lineP Foa, E Cofrancesco, L Lombardi, et al.
International Journal of Oncology|May 3, 2011
p53 protein accumulation and p53 gene alterations (RFLP, VNTR and p53 gene mutations) in non-invasive versus invasive human transitional bladder cancerR Shipman, P Schraml, H Moch, et al.
The British Journal of Dermatology|May 7, 2009
Branch point and donor splice-site COL7A1 mutations in mild recessive dystrophic epidermolysis bullosaB Drera, G Floriddia, F Forzano, et al.
Human Genetics|July 1, 1992
Exclusion of stromelysin-1, stromelysin-2, interstitial collagenase and fibronectin genes as the mutant loci in a family with recessive epidermolysis bullosa dystrophica and a form of cerebellar ataxiaM Colombi, R Gardella, N Zoppi, et al.
European Journal of Haematology|February 1, 1989
Bone marrow and tissue expression of gpIIb/IIIa, LFA-1, Mac-1 and gp150,95 glycoproteinsD Soligo, G Cattoretti, M Colombi, et al.
Journal of Occupational and Environmental Medicine|April 27, 2013
Six-year cost trends at PPG industries paralleling the introduction of health promotion programs directed at cardiovascular disease preventionRon Z Goetzel, Niranjana M Kowlessar, Rachel Henke, et al.
The British Journal of Dermatology|September 28, 2012
Compound heterozygosity of the novel -186C>T mutation in the COL7A1 promoter and the recurrent c.497insA mutation leads to generalized dystrophic epidermolysis bullosaM Ritelli, N Chiarelli, S Quinzani, et al.
Journal of Occupational and Environmental Medicine|December 3, 2010
The influence of worksite health promotion program management and implementation structure variables on medical care costs at PPG IndustriesNiranjana M Kowlessar, Rachel Mosher Henke, Ron Z Goetzel, et al.
International Journal of Cancer|March 15, 1994
RT-PCR detection of fibronectin EDA+ and EDB+ mRNA isoforms: molecular markers for hepatocellular carcinomaD Tavian, G De Petro, M Colombi, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Human Mutation|July 17, 1999
Three homozygous PTC mutations in the collagen type VII gene of patients affected by recessive dystrophic epidermolysis bullosa: analysis of transcript levels in dermal fibroblastsR Gardella, N Zoppi, S Ferraboli, et al.
British Journal of Cancer|November 1, 1983
Non interference by heparin with the cytostatic effect of adriamycin: an in vitro study on a human promyelocytic leukaemia cell lineP Foa, E Cofrancesco, L Lombardi, et al.
International Journal of Oncology|May 3, 2011
p53 protein accumulation and p53 gene alterations (RFLP, VNTR and p53 gene mutations) in non-invasive versus invasive human transitional bladder cancerR Shipman, P Schraml, H Moch, et al.
The British Journal of Dermatology|May 7, 2009
Branch point and donor splice-site COL7A1 mutations in mild recessive dystrophic epidermolysis bullosaB Drera, G Floriddia, F Forzano, et al.
Human Genetics|July 1, 1992
Exclusion of stromelysin-1, stromelysin-2, interstitial collagenase and fibronectin genes as the mutant loci in a family with recessive epidermolysis bullosa dystrophica and a form of cerebellar ataxiaM Colombi, R Gardella, N Zoppi, et al.
European Journal of Haematology|February 1, 1989
Bone marrow and tissue expression of gpIIb/IIIa, LFA-1, Mac-1 and gp150,95 glycoproteinsD Soligo, G Cattoretti, M Colombi, et al.
Journal of Occupational and Environmental Medicine|April 27, 2013
Six-year cost trends at PPG industries paralleling the introduction of health promotion programs directed at cardiovascular disease preventionRon Z Goetzel, Niranjana M Kowlessar, Rachel Henke, et al.
The British Journal of Dermatology|September 28, 2012
Compound heterozygosity of the novel -186C>T mutation in the COL7A1 promoter and the recurrent c.497insA mutation leads to generalized dystrophic epidermolysis bullosaM Ritelli, N Chiarelli, S Quinzani, et al.
Journal of Occupational and Environmental Medicine|December 3, 2010
The influence of worksite health promotion program management and implementation structure variables on medical care costs at PPG IndustriesNiranjana M Kowlessar, Rachel Mosher Henke, Ron Z Goetzel, et al.
International Journal of Cancer|March 15, 1994
RT-PCR detection of fibronectin EDA+ and EDB+ mRNA isoforms: molecular markers for hepatocellular carcinomaD Tavian, G De Petro, M Colombi, et al.
Pageof 11